Cite
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
MLA
Ossenkoppele, Rik, et al. “Discriminative Accuracy of [18F]Flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.” JAMA: Journal of the American Medical Association, vol. 320, no. 11, Sept. 2018, pp. 1151–62. EBSCOhost, https://doi.org/10.1001/jama.2018.12917.
APA
Ossenkoppele, R., Rabinovici, G. D., Smith, R., Cho, H., Schöll, M., Strandberg, O., Palmqvist, S., Mattsson, N., Janelidze, S., Santillo, A., Ohlsson, T., Jögi, J., Tsai, R., La Joie, R., Kramer, J., Boxer, A. L., Gorno-Tempini, M. L., Miller, B. L., Choi, J. Y., & Ryu, Y. H. (2018). Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA: Journal of the American Medical Association, 320(11), 1151–1162. https://doi.org/10.1001/jama.2018.12917
Chicago
Ossenkoppele, Rik, Gil D. Rabinovici, Ruben Smith, Hanna Cho, Michael Schöll, Olof Strandberg, Sebastian Palmqvist, et al. 2018. “Discriminative Accuracy of [18F]Flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.” JAMA: Journal of the American Medical Association 320 (11): 1151–62. doi:10.1001/jama.2018.12917.